JPMorgan Chase & Co. Boosts Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• JPMorgan Chase & Co. increased its stake in Henry Schein, Inc. by 6.5%, now holding 6,373,036 shares valued at approximately $436.5 million.
• Henry Schein's stock has been downgraded by several analysts, with an average rating of "Hold" and a target price of $75.58 as per recent research reports.
• The company reported earnings of $1.10 per share, missing estimates, but achieved a quarterly revenue of $3.24 billion, exceeding expectations.

JPMorgan Chase & Co. boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.5% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,373,036 shares of the company's stock after acquiring an additional 390,399 shares during the period. JPMorgan Chase & Co. owned 5.20% of Henry Schein worth $436,489,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Henry Schein during the first quarter valued at $1,024,000. Everett Harris & Co. CA grew its stake in shares of Henry Schein by 2.3% in the 1st quarter. Everett Harris & Co. CA now owns 160,127 shares of the company's stock worth $10,967,000 after buying an additional 3,570 shares in the last quarter. Citigroup Inc. grew its stake in shares of Henry Schein by 18.4% in the 1st quarter. Citigroup Inc. now owns 344,944 shares of the company's stock worth $23,625,000 after buying an additional 53,526 shares in the last quarter. CenterBook Partners LP purchased a new position in shares of Henry Schein in the 1st quarter worth $433,000. Finally, Ontario Teachers Pension Plan Board grew its stake in shares of Henry Schein by 797.9% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 37,543 shares of the company's stock worth $2,571,000 after buying an additional 33,362 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HSIC has been the subject of a number of recent research reports. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday, July 14th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Piper Sandler dropped their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Stifel Nicolaus reissued a "hold" rating and issued a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Nine equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $75.58.

Henry Schein Price Performance

Henry Schein stock opened at $66.10 on Tuesday. The firm has a 50-day moving average price of $71.00 and a 200-day moving average price of $71.00. The firm has a market capitalization of $8.02 billion, a PE ratio of 21.32, a price-to-earnings-growth ratio of 2.17 and a beta of 0.81. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the previous year, the business earned $1.23 EPS. The company's quarterly revenue was up 3.3% compared to the same quarter last year. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.